Relapsing neuromyelitis optica in an adolescent girl.
Vinita GuptaSaurabh LuthraShrey MaheshwariShrutanjoy M DasPublished in: BMJ case reports (2021)
Early differentiation of neuromyelitis optica spectrum disorder (NMO-SD) from multiple sclerosis (MS) is of paramount importance as NMO-SD (especially relapsing variant) has more severe morbidity than MS. We describe a case of an adolescent girl who presented with repeated episodes of optic neuritis over a period of 4 years with normal brain MRI scans. She was treated initially as relapsing remitting MS, before showing clinical evidence of transverse myelitis (TM), and eventually being diagnosed as NMO-SD. Pulse intravenous methyl prednisolone along with immunosuppressive therapy led to remission of her disease. However, delay in diagnosis as NMO-SD led to visual disability in the left eye. Therefore, in young patients with recurrent optic neuritis and normal brain MRI, it may be prudent to get spinal MRI done to look for TM, even when asymptomatic. In addition, we should keep a low threshold for requesting aquaporin-4 antibody testing in these patients.
Keyphrases
- multiple sclerosis
- white matter
- contrast enhanced
- magnetic resonance imaging
- young adults
- spectrum disorder
- end stage renal disease
- diffusion weighted imaging
- newly diagnosed
- mental health
- computed tomography
- ejection fraction
- resting state
- chronic kidney disease
- optical coherence tomography
- magnetic resonance
- blood pressure
- mass spectrometry
- peritoneal dialysis
- rheumatoid arthritis
- disease activity
- prognostic factors
- stem cells
- high dose
- optic nerve
- systemic lupus erythematosus
- early onset
- mesenchymal stem cells
- ulcerative colitis
- childhood cancer
- drug induced